GeneproDX
vcLATAM
GeneproDX is a Chilean biotech startup developing ThyroidPrint, a diagnostic test that improves accuracy for thyroid cancer detection. The company has raised venture capital funding, including a US$3.3M round and a US$1.4M investment from Fondo Alerce. It is not an investor but a portfolio company.